Article (Scientific journals)
XAB2 promotes Ku eviction from single-ended DNA double-strand breaks independently of the ATM kinase.
Sharma, Abhishek Bharadwaj; Erasimus, Hélène; Pinto, Lia et al.
2021In Nucleic Acids Research, 49 (17), p. 9906-9925
Peer Reviewed verified by ORBi
 

Files


Full Text
gkab785.pdf
Author postprint (9.13 MB) Creative Commons License - Attribution
Download

All documents in ORBilu are protected by a user license.

Send to



Details



Keywords :
Alkylating Agents; MRE11 protein, human; RAD52 protein, human; RNA Splicing Factors; RNA, Small Interfering; Rad52 DNA Repair and Recombination Protein; XAB2 protein, human; EC 2.7.11.1 (ATM protein, human); EC 2.7.11.1 (Ataxia Telangiectasia Mutated Proteins); EC 2.7.7.- (RAD51 protein, human); EC 2.7.7.- (Rad51 Recombinase); EC 3.1.- (Endodeoxyribonucleases); EC 3.1.- (MRE11 Homologue Protein); EC 3.1.- (RBBP8 protein, human); EC 3.6.4.12 (XRCC5 protein, human); EC 4.2.99.- (Ku Autoantigen); XT3Z54Z28A (Camptothecin); YF1K15M17Y (Temozolomide); Alkylating Agents/adverse effects/pharmacology; Ataxia Telangiectasia Mutated Proteins/metabolism; Camptothecin/adverse effects/pharmacology; Cell Line, Tumor; DNA Breaks, Double-Stranded; DNA End-Joining Repair/genetics; Endodeoxyribonucleases/metabolism; Glioblastoma/drug therapy; Homologous Recombination/genetics; Humans; Ku Autoantigen/metabolism; MRE11 Homologue Protein/metabolism; RNA Interference; RNA Splicing Factors/genetics/metabolism; RNA, Small Interfering/genetics; Rad51 Recombinase/metabolism; Rad52 DNA Repair and Recombination Protein/metabolism; Temozolomide/adverse effects/pharmacology
Abstract :
[en] Replication-associated single-ended DNA double-strand breaks (seDSBs) are repaired predominantly through RAD51-mediated homologous recombination (HR). Removal of the non-homologous end-joining (NHEJ) factor Ku from resected seDSB ends is crucial for HR. The coordinated actions of MRE11-CtIP nuclease activities orchestrated by ATM define one pathway for Ku eviction. Here, we identify the pre-mRNA splicing protein XAB2 as a factor required for resistance to seDSBs induced by the chemotherapeutic alkylator temozolomide. Moreover, we show that XAB2 prevents Ku retention and abortive HR at seDSBs induced by temozolomide and camptothecin, via a pathway that operates in parallel to the ATM-CtIP-MRE11 axis. Although XAB2 depletion preserved RAD51 focus formation, the resulting RAD51-ssDNA associations were unproductive, leading to increased NHEJ engagement in S/G2 and genetic instability. Overexpression of RAD51 or RAD52 rescued the XAB2 defects and XAB2 loss was synthetically lethal with RAD52 inhibition, providing potential perspectives in cancer therapy.
Disciplines :
Oncology
Author, co-author :
Sharma, Abhishek Bharadwaj ;  DNA Repair and Chemoresistance Group, Department of Oncology, Luxembourg Institute of Health (LIH), Luxembourg, Luxembourg.
Erasimus, Hélène;  DNA Repair and Chemoresistance Group, Department of Oncology, Luxembourg Institute of Health (LIH), Luxembourg, Luxembourg. ; Faculty of Science, Technology and Communication, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
Pinto, Lia;  DNA Repair and Chemoresistance Group, Department of Oncology, Luxembourg Institute of Health (LIH), Luxembourg, Luxembourg. ; Faculty of Science, Technology and Communication, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
Caron, Marie-Christine;  CHU de Québec Research Center, Oncology Division, Québec City, Canada. ; Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University Cancer Research Center, Québec City, Canada.
Gopaul, Diyavarshini;  Institut de Génétique Humaine, CNRS et Université de Montpellier, Equipe Labellisée Ligue Contre le Cancer, Montpellier, France.
Peterlini, Thibaut;  CHU de Québec Research Center, Oncology Division, Québec City, Canada. ; Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University Cancer Research Center, Québec City, Canada.
Neumann, Katrin;  DNA Repair and Chemoresistance Group, Department of Oncology, Luxembourg Institute of Health (LIH), Luxembourg, Luxembourg.
NAZAROV, Petr  ;  Quantitative Biology Unit, Multiomics Data Science Group, LIH, Luxembourg.
FRITAH, Sabrina ;  NorLux Neuro-Oncology Laboratory, Department of Oncology, LIH, Luxembourg.
KLINK, Barbara ;  National Center of Genetics, Laboratoire National de Santé, Dudelange, Luxembourg. ; Functional Tumour Genetics Group, Department of Oncology, LIH, Luxembourg.
Herold-Mende, Christel C;  Department of Neurosurgery, University Clinic Heidelberg, Heidelberg, Germany.
NICLOU, Simone P. ;  NorLux Neuro-Oncology Laboratory, Department of Oncology, LIH, Luxembourg. ; Department of Biomedicine, University of Bergen, Norway.
Pasero, Philippe;  Institut de Génétique Humaine, CNRS et Université de Montpellier, Equipe Labellisée Ligue Contre le Cancer, Montpellier, France.
Calsou, Patrick ;  Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France, Equipe Labellisée Ligue Nationale Contre le Cancer 2018.
Masson, Jean-Yves;  CHU de Québec Research Center, Oncology Division, Québec City, Canada. ; Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University Cancer Research Center, Québec City, Canada.
Britton, Sébastien ;  Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France, Equipe Labellisée Ligue Nationale Contre le Cancer 2018.
Van Dyck, Eric ;  DNA Repair and Chemoresistance Group, Department of Oncology, Luxembourg Institute of Health (LIH), Luxembourg, Luxembourg.
More authors (7 more) Less
External co-authors :
yes
Language :
English
Title :
XAB2 promotes Ku eviction from single-ended DNA double-strand breaks independently of the ATM kinase.
Publication date :
27 September 2021
Journal title :
Nucleic Acids Research
ISSN :
0305-1048
eISSN :
1362-4962
Publisher :
Oxford University Press, United Kingdom
Volume :
49
Issue :
17
Pages :
9906-9925
Peer reviewed :
Peer Reviewed verified by ORBi
Funding number :
FDN388879/CIHR/Canada
Commentary :
© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.
Available on ORBilu :
since 26 February 2024

Statistics


Number of views
113 (1 by Unilu)
Number of downloads
49 (1 by Unilu)

Scopus citations®
 
10
Scopus citations®
without self-citations
8
OpenCitations
 
6
OpenAlex citations
 
12

Bibliography


Similar publications



Contact ORBilu